Answers Are in the Blood: cfDNA to Enhance Precision Medicine for Breast Cancer.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 33837007.
- Also identified by DOI 10.1158/1078-0432.CCR-21-0353.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Identification of biomarkers to drive treatment using cell-free DNA allows dynamic and safe assessment of tumor biology representing an important advance adding to tissue-based genotyping. Caution must be exercised interpreting commercial matching information as validation is often lacking, and true matching is feasible in a minority of patients.<i>See related article by Vidula et al., p. 3404</i>.
Medical subject headings
- Breast Neoplasms
- Cell-Free Nucleic Acids